A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
Clinical trial NCT05098938 · COMPLETED
Trial details
- NCT number
- NCT05098938
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2023-07-19
- Enrollment
- 2020
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.